7-32543256-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_015060.3(AVL9):c.209A>T(p.Gln70Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015060.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AVL9 | NM_015060.3 | c.209A>T | p.Gln70Leu | missense_variant | 2/16 | ENST00000318709.9 | NP_055875.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AVL9 | ENST00000318709.9 | c.209A>T | p.Gln70Leu | missense_variant | 2/16 | 2 | NM_015060.3 | ENSP00000315568.4 | ||
AVL9 | ENST00000409301.5 | c.209A>T | p.Gln70Leu | missense_variant | 2/15 | 5 | ENSP00000387011.1 | |||
AVL9 | ENST00000446718.1 | c.2A>T | p.Gln1Leu | missense_variant | 1/13 | 5 | ENSP00000395134.1 | |||
AVL9 | ENST00000485228.1 | n.378-8078A>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000877 AC: 22AN: 250886Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135572
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461582Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727076
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.209A>T (p.Q70L) alteration is located in exon 2 (coding exon 2) of the AVL9 gene. This alteration results from a A to T substitution at nucleotide position 209, causing the glutamine (Q) at amino acid position 70 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at